Sarepta stock surged after the pharma company said it would lay off a third of its workforce and add a black-box warning to ...

Sarepta Therapeutics appears to have right-sized itself after laying off over a third of its staff, announcing a significant ...

The company is also pausing research for several treatments it has been developing for another form of muscular dystrophy.

Sarepta stock is flying. It has a way to go to reach past heights, however. Shares of drug developer Sarepta Therapeutics (SRPT) surged more than 20% in morning trading, rising after the ...

Sarepta Therapeutics said it will eliminate 36% of its workforce—approximately 500 jobs—in a restructuring that follows the ...

Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Taiwan Semiconductor Manufacturing reports a record profit in the second quarter, PepsiCo’s adjusted earnings top forecasts, ...